Ops! Seems as though I was dead wrong about Novartis not having a regenerative medicine division. Dr. Michael Perry seems to be in charge of such a division, although it is called "Stem Cell Therapy." Apologies.
"Dr Michael S. Perry, Vice President and Senior Global Program Head, Stem Cell Therapy at Novartis Pharmaceuticals Corp.. . . "
Ops! Seems as though I was dead wrong about Novartis not having...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |